Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Warrants issued and outstanding (Details)

v3.20.4
Stockholders' Equity - Warrants issued and outstanding (Details)
 12 Months Ended
Dec. 17, 2018
USD ($)
shares
Sep. 30, 2020
USD ($)
EquityInstruments
$ / shares
shares
Sep. 30, 2019
USD ($)
$ / shares
shares
Warrants [Roll Forward]      
Exercise Price   $ 8.73  
Warrants, Outstanding at the beginning of the period | shares   728,439 0
Warrants, Exercised | shares     (103,787)
Warrants, Redeemed | shares     (76,501)
Warrants, Issued | shares   105,000  
Warrants, Expired | shares   (12,500)  
Warrants, Outstanding at the end of the period | shares   820,939 728,439
Warrants, Exercisable at the end of the period | shares   750,939  
Weighted average exercise price, Outstanding at the beginning of the period   $ 20.99 $ 0
Weighted average exercise price, Exercised     0
Weighted average exercise price, Redeemed     55.00
Weighted average exercise price, Issued   8.73  
Weighted average exercise price, Expired   20.00  
Weighted average exercise price, Outstanding at the end of the period   19.44 $ 20.99
Weighted average exercise price, Exercisable at the end of the period   $ 20.44  
Weighted average remaining contractual term, Outstanding at the end of the period   1 year 8 months 12 days 0 years
Weighted average remaining contractual term, Exercisable at the end of the period   1 year 7 months 6 days  
Warrants vesting period   6 months  
Exercise price of warrants (in dollars per share)   $ 8.73  
Initial fair value of warrants | $   $ 496,343 $ 950,151
Class of Warrant or Right, Right to Receive, Shares | shares     103,787
CMU      
Warrants [Roll Forward]      
Assumed, Issued in connection with acquisition | shares     103,787
Weighted average exercise price, Issued in connection with license acquired     $ 0
Ohr      
Warrants [Roll Forward]      
Assumed, Issued in connection with acquisition | shares     804,940
Weighted average exercise price, Issued in connection with license acquired     $ 24.22
Number of Warrants Recorded as Derivative Liability | EquityInstruments   792,440  
Number of Warrants Recorded as Equity | EquityInstruments   12,500  
Warrants Acquired, Redeemed in Cash | $     $ 100,000
License Agreement with Carnegie Mellon University      
Warrants [Roll Forward]      
Stock issued, purchase of assets | shares 835,625 820,000  
Funding amount | $ $ 2,000,000    
Fully-diluted common stock held (in percent) 8.20%    
License Agreement with Carnegie Mellon University | CMU      
Warrants [Roll Forward]      
Exercise Price     $ 10.00
Exercise price of warrants (in dollars per share)     $ 10.00
Stock issued, purchase of assets | shares     820,000
Funding amount | $     $ 2,000,000
Fully-diluted common stock held (in percent)     8.20%
Number of Days to Consider Qualified Sale     30 years
Class of Warrant or Right, Exercisable | shares     101,847
December 13, 2021      
Warrants [Roll Forward]      
Exercise Price   $ 55.00  
Warrants, Outstanding at the end of the period | shares   20,627  
Exercise price of warrants (in dollars per share)   $ 55.00  
April 10, 2022      
Warrants [Roll Forward]      
Exercise Price   $ 20.00  
Warrants, Outstanding at the end of the period | shares   695,312  
Exercise price of warrants (in dollars per share)   $ 20.00  
July 6, 2023      
Warrants [Roll Forward]      
Exercise Price   $ 8.73  
Warrants, Outstanding at the end of the period | shares   105,000  
Exercise price of warrants (in dollars per share)   $ 8.73